Bioethic Pharma S.A.
Between 2014 and 2026 in DNCP awards, Bioethic Pharma S.A. appears as a supplier in 350 records from DNCP awards and DNCP tenders; in DNCP awards that is 179 unique processes. The observed amount totals 585B PYG. The leading buyer by amount, Ministerio de Salud Pública y Bienestar Social (MSPBS), accounts for 75.7% of the PYG amount. In Sep 2026, the number of processes is unchanged from Aug 2026.
Create and download this entity’s chart- Source records
- 350
- Sources
- 2
Observed volume
179 processes
179 source rows in DNCP awards. Counts from other sources remain separate.
Latest activity
Sep 2026
2 records in the period.
Latest comparable change
No change
Aug 2026 → Sep 2026 · same value
Leading buyer by amount
75.7% of observed PYG amount; top three 98.5%.
History
Historical series by source
4 independent series
Relationships
Top counterparties in the records
Ranked by shared record count, without adding different currencies.
Relationship concentration
Reliance on leading counterparties
Each currency is calculated separately. A high share may reflect specialization, scale, or source coverage and is not by itself evidence of misconduct.
Recent activity
Latest published records
Ordered by the most relevant award, publication, or event date in each source. An identical event published by multiple lifecycle sources is shown once and retains every source in the first column. This does not claim the activity happened today.
| Source | Award date | Publication date | Title | Buyer | Status | Amount | Currency |
|---|---|---|---|---|---|---|---|
| DNCP awards | Sep 29, 2026 | Oct 20, 2025 | SBEN N° 15/2025 - ADQUISICION DE MEDICAMENTOS E INSUMOS PARA EL INSTITUTO NACIONAL DE NEFROLOGIA - MSPYBS | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲550,394,496 | PYG |
| DNCP awards | Sep 22, 2026 | Jul 24, 2026 | LPN Nº 60 /2026 -ADQUISICION DE INSULINA PARA EL PROGRAMA NACIONAL DE DIABETES | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲2,744,049,000 | PYG |
| DNCP awards | Aug 24, 2026 | May 18, 2026 | LPN N° 11/26 ADQUISICIÓN DE MEDICAMENTOS PARA ASEGURADOS DEL IPS – SOLPED 1130000530 | Instituto de Previsión Social (IPS) | publicado | ₲409,760,000 | PYG |
| DNCP awards | Aug 10, 2026 | Jun 11, 2026 | LPN Nº 17/2026 - ADQUISICIÓN DE MEDICAMENTOS PARA EL INSTITUTO NACIONAL DE ABLACIÓN Y TRASPLANTE - MSPBS | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲112,000,000 | PYG |
| DNCP awards | Jun 19, 2026 | Sep 11, 2025 | LPN N° 103/2025 - ADQUISICION DE MEDICAMENTOS E INSUMOS PARA EL INSTITUTO NACIONAL DE ABLACION Y TRASPLANTE - MSPBS | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲1,656,960,000 | PYG |
| DNCP awards | May 06, 2026 | Dec 17, 2025 | ADQUISICIÓN DE MEDICAMENTOS PARA EL HOSPITAL DE CLÍNICAS - AD REFERENDUM 2026. | Universidad Nacional de Asunción (UNA) | publicado | ₲59,184,000 | PYG |
| DNCP awards | Feb 12, 2026 | Sep 16, 2025 | LPN N° 26/2025 "ADQUISICION DE PALBOCICLIB 125 MG PARA PACIENTES DEL INCAN Y OTROS CENTROS DEPENDIENTES DEL MINISTERIO DE SALUD PUBLICA Y BIENESTAR SOCIAL - PLURIANUAL - CONTRATO ABIERTO" | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲6,321,332,000 | PYG |
| DNCP awards | Nov 20, 2025 | Sep 15, 2025 | LPN N° 98/2025 - ADQUISICION DE INFLIXIMAB Y TOCILIZUMAB PARA PACIENTES CON ENFERMEDADES REUMATICAS, AUTOINMUNES Y SISTEMICAS DEL MSPYBS | Ministerio de Salud Pública y Bienestar Social (MSPBS) | publicado | ₲42,120,000,000 | PYG |
| DNCP awards | Nov 20, 2025 | Sep 23, 2025 | ADQUISICION DE MEDICAMENTOS VARIOS PARA EL HOSPITAL CENTRAL DE POLICIA RIGOBERTO CABALLERO” – PLURIANUAL | Ministerio del Interior (M.I.) | publicado | ₲536,000,000 | PYG |
Entity monitoring
Monitor Bioethic Pharma S.A.
Get an email when linked records change. Alerts make clear that a change may be new activity, broader coverage, or a source correction.
Cross-source check
Matches requiring verification
The same identifier or exact normalized name appears under another role. This directs an investigation but does not prove that both mentions are the same entity.
Coverage and provenance
Sources contributing to this profile
Cross-source matches use exact identifiers or exact normalized names and do not by themselves prove identity.
Headline activity and concentration use DNCP adjudicaciones; source histories are kept separate and are never added across datasets.
This profile consolidates source keys within one country and role only through exact identifiers or an unambiguous normalized legal name. Currencies and unit scales remain separate; similar names are not assumed to be the same organization.